TUBB4A

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, TUBB4A mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated TUBB4A data layer compared with 22 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher TUBB4A mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated TUBB4A expression acts as an unfavorable survival marker, although some lineages such as PDAC and CCRCC show a favorable association.

PDAC, CCRCC, and HNSC are the cancer types where TUBB4A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
PDACOSMedianIII,IV0.9620.599.00717view →
CCRCCDFSTertileAll0.9580.426.00615view →
HNSCOSMedianAll1.0000.449.02312view →
UCECOSQuartileAll0.7871.000.01712view →
LUADOSQuartileIII,IV0.8390.233.0114view →
LSCCOSMedianII,III,IV0.8101.000.0352view →
Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

TUBB4A–PDAC (OS)

Kaplan–Meier survival curve for TUBB4A mass-spec protein-high vs -low samples in PDAC.

Open the PDAC breakdown →

Exploration